Patients with prosthetic joint infection on IV antibiotics are at high risk for readmission

Area of Science:

• Orthopedics
• Infectious Diseases
• Pharmacology

Background:

• Prosthetic joint infections (PJI) are a growing concern due to increased joint replacement surgeries.
• Community-based parenteral anti-infective therapy (CoPAT) is the standard treatment for most PJIs post-surgery.
• Limited data exists on short-term complications associated with CoPAT.

Purpose of the Study:

• To determine the incidence of short-term complications following CoPAT for PJI.
• To assess unanticipated readmissions, unplanned surgeries, and CoPAT-related adverse events within 12 weeks of discharge.

Main Methods:

• Retrospective chart review of 74 patients with PJI treated with CoPAT.
• Analysis of readmission reasons, surgical interventions, and adverse events within a 12-week period.

Main Results:

• 27% of patients experienced readmission within 12 weeks, with 73% of these being for unanticipated reasons.
• 16% of readmitted patients required unplanned surgery.
• 9% of the total cohort suffered CoPAT-related adverse events.

Conclusions:

• Patients with PJI receiving CoPAT represent a high-risk group for early post-discharge complications.
• Close monitoring for adverse events and complications is crucial in the early period after hospital discharge.
• Further research into optimizing CoPAT protocols and patient monitoring is warranted.